BOUT:NYE-Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 33.6309

Change

+0.02 (+0.07)%

Market Cap

USD 0.01B

Volume

1.61K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-01 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

+3.38 (+2.78%)

USD 16.21B
VOT Vanguard Mid-Cap Growth Index ..

+3.69 (+1.47%)

USD 14.12B
IJK iShares S&P Mid-Cap 400 Growth..

+2.20 (+2.63%)

USD 7.96B
XMMO Invesco S&P MidCap Momentum ET..

+3.50 (+3.02%)

USD 3.25B
IVOG Vanguard S&P Mid-Cap 400 Growt..

+2.84 (+2.74%)

USD 0.98B
ETHO Amplify ETF Trust

+1.12 (+2.08%)

USD 0.18B
CWS AdvisorShares Focused Equity E..

+1.07 (+1.65%)

USD 0.17B
BFOR Barron's 400 ETF

+1.66 (+2.40%)

USD 0.14B
IPO Renaissance IPO ETF

+1.21 (+3.11%)

USD 0.12B
PEXL Pacer US Export Leaders ETF

+1.15 (+2.55%)

USD 0.04B

ETFs Containing BOUT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -13.92% 6% D- 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.92% 6% D- 18% F
Trailing 12 Months  
Capital Gain -2.00% 50% F 38% F
Dividend Return 0.02% 8% B- N/A F
Total Return -1.99% 50% F 30% F
Trailing 5 Years  
Capital Gain 69.77% 50% F 65% D
Dividend Return 4.25% 44% F 8% B-
Total Return 74.01% 33% F 58% F
Average Annual (5 Year Horizon)  
Capital Gain 9.92% 72% C 68% D+
Dividend Return 10.53% 72% C 64% D
Total Return 0.61% 50% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 20.79% 61% D- 49% F
Risk Adjusted Return 50.64% 72% C 66% D+
Market Capitalization 0.01B 8% B- 8% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.